0001209191-23-009734.txt : 20230215 0001209191-23-009734.hdr.sgml : 20230215 20230215162542 ACCESSION NUMBER: 0001209191-23-009734 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230213 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS ROBERT T. JR. CENTRAL INDEX KEY: 0001563606 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 23635708 MAIL ADDRESS: STREET 1: INTEGRA LIFESCIENCES CORPORATION STREET 2: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-13 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001563606 DAVIS ROBERT T. JR. 1100 CAMPUS ROAD PRINCETON NJ 08540 0 1 0 0 EVP & President, TT Common Stock 2023-02-13 4 A 0 2379 0.00 A 41191 D Common Stock 2023-02-13 4 A 0 1067 0.00 A 42258 D Common Stock 2023-02-13 4 A 0 1779 0.00 A 44037 D Common Stock 2023-02-13 4 A 0 1883 0.00 A 45920 D On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. /s/ Eric Schwartz; Attorney-in-Fact 2023-02-15